Clinical Trial Update: Combination Trastuzumab With Expanded Natural Killer Cells for Treating HER2-positive Gastric Cancer [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update evaluating the combination of trastuzumab with expanded natural killer cells for HER2-positive gastric cancer across Phase 1 and Phase 2…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• Expanded Natural Killer Cells (expanded natural killer cells)
• HERCEPTIN (trastuzumab)

Snippet

Sponsor: Xuzhou Medical University | Conditions: Gastric Cancer | Phase 1, Phase 2 | Status: UNKNOWN